| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.22 | 0.006 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.0005 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.3 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.13 | 0.07 |